US Stock MarketDetailed Quotes

CYCN Cyclerion Therapeutics

Watchlist
  • 5.2000
  • -1.1500-18.11%
Trading Dec 5 14:40 ET
14.09MMarket Cap-2441P/E (TTM)

Cyclerion Therapeutics Key Stats

Cyclerion Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2022/Q30.000 / 153.000K--
--2022/Q2306.000K / 355.500K--
--2022/Q1711.000K / 275.000K--
--2021/Q4533.000K / 900.000K--
--2021/Q3348.000K / 1.500M--
DatePeriodRevenue/EstimateEarnings Call
--2022/Q30.000 / 153.000K--
--2022/Q2306.000K / 355.500K--
--2022/Q1711.000K / 275.000K--
--2021/Q4533.000K / 900.000K--
--2021/Q3348.000K / 1.500M--

Unlock Free Earnings Estimates

Cyclerion Therapeutics Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.